Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 398.33M P/E - EPS this Y 87.50% Ern Qtrly Grth -
Income -15.54M Forward P/E 46.22 EPS next Y 700.00% 50D Avg Chg 9.00%
Sales 446.55M PEG 0.34 EPS past 5Y -25.46% 200D Avg Chg 43.00%
Dividend N/A Price/Book 7.27 EPS next 5Y -259.10% 52W High Chg -3.00%
Recommedations 1.50 Quick Ratio 0.86 Shares Outstanding 100.27M 52W Low Chg 130.00%
Insider Own 3.24% ROA 0.41% Shares Float 96.52M Beta 1.41
Inst Own 56.52% ROE -31.49% Shares Shorted/Prior 4.07M/5.21M Price 4.16
Gross Margin 32.05% Profit Margin -3.48% Avg. Volume 696,182 Target Price 6.13
Oper. Margin 3.73% Earnings Date Nov 5 Volume 293,088 Change -1.19%
About Accuray Incorporated

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Accuray Incorporated News
11/07/24 Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks
11/07/24 Accuray Inc (ARAY) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
11/06/24 Accuray (ARAY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11/06/24 Accuray (ARAY) Reports Q1 Loss, Tops Revenue Estimates
11/06/24 Accuray: Fiscal Q1 Earnings Snapshot
11/06/24 Accuray Reports Fiscal 2025 First Quarter Financial Results
10/31/24 Accolade And 2 Other Penny Stocks To Watch On US Exchanges
10/23/24 Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
03:05 PM Accuray Appoints Michael Murphy as VP, Corporate Controller
10/17/24 Here's Why You Should Retain Accuray Stock in Your Portfolio Now
10/17/24 New England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer
10/15/24 Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence
09/30/24 Genolier Health Innovation Hub opens in Switzerland
09/30/24 Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife® S7™ System Medical Professional Training
09/16/24 ARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan
09/15/24 Accuray (NASDAQ:ARAY) shareholders are up 14% this past week, but still in the red over the last three years
09/10/24 Gifu Prefectural General Medical Center Achieves Milestone with Treatment of the First Cancer Patients in Japan Using the Accuray Radixact® System and VitalHold™ Solution
09/03/24 Accuray President and Chief Executive Officer Suzanne Winter to Take Temporary Medical Leave of Absence
08/28/24 Accuray Stock Rises After Helix System Wins CE Mark for Cancer Care
08/28/24 Accuray’s helical radiation delivery system secures CE Mark approval
ARAY Chatroom

User Image Stocksrunner Posted - 1 week ago

$NINE $CRBU $CLNE $ADV $ARAY all hit their LOWEST points today but powered through to CLOSE HIGHER! 🚀📈watch out for more action! 🔥

User Image MSUalum Posted - 1 week ago

$ARAY beat, beat, raise. Needs more cost cutting initiatives but getting there, slowly.

User Image DonCorleone77 Posted - 2 weeks ago

$ARAY Accuray reports Q1 EPS (4c), consensus (5c) Reports Q1 revenue $101.5M, consensus $97.55M. We continue to make solid progress in the execution of our strategic growth agenda and performed better than expected in the first quarter and are on track to deliver our fiscal 2025 plan. Our performance in the China region was strong and we saw significant interest in the recently introduced Accuray Tomo C System and growth in our service business. I could not be more excited about where we are, as the company executes our strategy to drive top line and adjusted EBITDA growth transforming our competitive position in the global radiotherapy market," said Suzanne Winter, Chief Executive Officer.

User Image Scanners_Free Posted - 2 weeks ago

$ARAY BEAT BOTH TOP AND BOTTOM

User Image Convinvestor Posted - 2 weeks ago

$ARAY this has strong potential to explode today after earnings.

User Image DARKP00L Posted - 2 weeks ago

$ARAY this stock is seeing a surge in interest. Market volatility might ensue!

User Image Tallcat23679 Posted - 10/31/24

$ARAY Down 5% for no obvious reason.

User Image Estimize Posted - 10/28/24

Wall St is expecting 97.55 revenue for $ARAY Q1 [Reporting 11/06 AMC] http://www.estimize.com/intro/aray?chart=historical&metric_name=reven

User Image WeeklyTrader Posted - 10/23/24

What’s making you excited about $ARAY? RSI: 44.51% 50-day MA: $1.96 200-day MA: $2.12

User Image MSUalum Posted - 1 month ago

$ARAY CEO is back to work, time to get this moving again.

User Image Tallcat23679 Posted - 1 month ago

$ARAY. Someone bought suddenly

User Image WeeklyTrader Posted - 1 month ago

Celebrate gains with $ARAY! RSI: 46.22% 50-day MA: $1.91 200-day MA: $2.15

User Image VinWeezel Posted - 1 month ago

$ARAY does all this good news turn into profit?

User Image biggsk Posted - 09/30/24

$ARAY https://www.prnewswire.com/news-releases/accuray-celebrates-opening-of-genolier-innovation-hub-in-switzerland-initiation-of-cyberknife-s7-system-medical-professional-training-302262088.html

User Image MSUalum Posted - 09/27/24

$ARAY insiders, where art thou? Suzanne?

User Image biggsk Posted - 09/27/24

$ARAY https://www.marketbeat.com/instant-alerts/nasdaq-aray-sec-filing-2024-09-27/

User Image Starlord10 Posted - 2 months ago

$ARAY been waiting for an entry since it ran up to $2.5. Figured it might retrace to this mid$1.7 level. How bad is this latest screw up, think it might fill the gap at $1.46?

User Image Georges8792 Posted - 2 months ago

$ARAY so bad

User Image MSUalum Posted - 2 months ago

$ARAY those 3 extra days they needed cost investors millions and couldn't have been worse timing. Amateur hour.

User Image Dieseld28 Posted - 2 months ago

$ARAY 🍋

User Image MSUalum Posted - 2 months ago

$ARAY important to again note that the CEO still owns over 1.3M shares, so getting the company in order and sold represents a nice payday. Hope the BoD does their fudiciary duty here after failing for so long.

User Image Georges8792 Posted - 2 months ago

$ARAY starting to sell today so everybody who thinks that this mismanaged company is so cheap please put in some nice bids. Thx

User Image CDRPickle Posted - 2 months ago

$ARAY Unbelievable ... overpaid incompetent leadership and BOD!This is a small company and because of their incompetence they just cost the owners $28M in one single day. This is 100% on them. Getting their 10-K together and on-time is their job! It's not rocket science. And compared to their market cap and growth rate their salaries are ridiculous and now they aren't even doing their basic job functions. I vote sell the company as the engineers deserve better management as do the customers.

User Image Tallcat23679 Posted - 2 months ago

$ARAY. Quite a dichotomy between the product, Cyberknife, and the viability and poor governance and what would seem to be a major innovation in cancer therapy. What am I missing? Is it up and coming competitive and superior product?

User Image MSUalum Posted - 2 months ago

$ARAY I agree with posters here....this has become a pit and they should be setting up a sale on the cheap (3.75ish) asap. The BoD has failed once again, worthless bunch. Inexcusable dumb things; I just looked and they have been on SAP for over a year and are now using it as an excuse for an NT filing - pulled a fast one on me. They spent nearly 6M last year on the SAP implementation! Better hope no restatements on the past 4 filings....watching close.

User Image Georges8792 Posted - 2 months ago

$ARAY what a mess … always able to surprise with bad news

User Image UstaStockman Posted - 2 months ago

$ARAY Profitable company trading at less than 1 x sales and issuing strong fy2025 guidance this will move higher has multibagger written all over it

User Image Dieseld28 Posted - 2 months ago

$ARAY ARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan https://finance.yahoo.com/news/aray-stock-following-sgrt-cancer-170500176.html/

User Image Dieseld28 Posted - 2 months ago

$ARAY adding new highs will print

User Image Georges8792 Posted - 2 months ago

$ARAY at some point it is time to take the losses and move on

Analyst Ratings
Roth MKM Buy Feb 13, 24
B. Riley Securities Buy Oct 4, 23
BTIG Buy Jun 24, 22
B. Riley Securities Buy Jun 23, 22
Loop Capital Buy Dec 22, 21
BTIG Buy Jan 21, 20
Citigroup Neutral Nov 1, 18
Citigroup Sell Aug 17, 18
JP Morgan Underweight Dec 13, 17
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Spine Patrick SVP, Chief Admin Off.. SVP, Chief Admin Officer Nov 30 Sell 2.4712 14,832 36,653 219,484 12/04/23
Winter Suzanne C President President Nov 30 Sell 2.47 65,390 161,513 1,369,811 12/04/23
Pervaiz Ali SVP Chief Financial.. SVP Chief Financial Officer Nov 30 Sell 2.47 13,463 33,254 404,859 12/04/23
Chew Jesse SVP, General Counsel SVP, General Counsel Nov 30 Sell 2.47 29,770 73,532 381,920 12/04/23
Hoge Michael Senior VP Global Ope.. Senior VP Global Operations Nov 30 Sell 2.47 19,212 47,454 402,199 12/04/23
Chalke Sandeep SVP, Chief Commercia.. SVP, Chief Commercial Officer Nov 30 Sell 2.47 14,585 36,025 555,640 12/04/23
Winter Suzanne C President President Nov 01 Sell 2.57 38,338 98,529 1,436,616 11/03/23
Pervaiz Ali SVP Chief Financial.. SVP Chief Financial Officer Oct 31 Sell 2.5837 3,303 8,534 401,857 11/01/23
Winter Suzanne C President President Jul 03 Sell 3.82 17,085 65,265 1,492,073 07/03/23
Spine Patrick SVP, Chief Admin Off.. SVP, Chief Admin Officer Dec 01 Sell 2.096 5,176 10,849 208,561 12/02/22
Winter Suzanne C President President Dec 01 Sell 2.096 9,823 20,589 721,758 12/02/22
Chew Jesse SVP, General Counsel SVP, General Counsel Dec 01 Sell 2.096 5,976 12,526 246,480 12/02/22
Hoge Michael Senior VP Global Ope.. Senior VP Global Operations Dec 01 Sell 2.096 5,531 11,593 286,373 12/02/22
Spine Patrick SVP, Chief Admin Off.. SVP, Chief Admin Officer May 04 Sell 2.650 1,559 4,131 225,094 05/05/22
Hoge Michael Senior VP Global Ope.. Senior VP Global Operations Mar 01 Sell 3.4305 11,653 39,976 300,228 03/08/22
Winter Suzanne C President President Jan 31 Buy 3.53 761 2,686 659,105 02/07/22
LEVINE JOSHUA President & CEO President & CEO Dec 02 Sell 4.07 15,674 63,793 1,029,538 12/02/20